Quantum-Si to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

BRANFORD, Conn.–(BUSINESS WIRE)–Feb. 9, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will report financial results for the fourth quarter and full year 2023 on Thursday, February 29, 2024. Company management will host a conference call to discuss financial results and provide a business update […]

Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing™ Platform

Addition of another amino acid recognizer combined with improvements in surface chemistry, reagents and software will offer Platinum users greater sequencing output and coverage per sample BRANFORD, Conn.–(BUSINESS WIRE)–Feb. 5, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the launch of new platform enhancements for Platinum®, with […]

Quantum-Si Introduces World’s First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor

BRANFORD, Conn.–(BUSINESS WIRE)–Jan. 18, 2024– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new distributor who will make the company’s protein sequencing instrument, Platinum® available for the first time in Japan. TOMY Digital Biology Co., Ltd., a renowned importer […]

Quantum-Si Expands Global Reach with Addition of New Distributor

BRANFORD, Conn.–(BUSINESS WIRE)–Dec. 12, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new international distributor as demand grows for its first-to-market next-generation protein sequencing™ instrument, Platinum™. 3Genes Distribution a.s., a prominent technology provider specializing in life science and […]

Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum™ Grows

BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 15, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it had entered into an agreement with Elta 90 to distribute Quantum-Si’s groundbreaking Platinum™ instrument and consumables in Southeast Europe as demand grows for the first of its kind next-generation protein sequencing™ platform. This […]

Quantum-Si Reports Third Quarter 2023 Financial Results

BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 9, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights Recorded revenue of $223,000 in the third quarter of 2023 as the Company continued its previously communicated controlled commercial launch of its […]

Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards

BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 8, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it has received the “Proteomics Company of the Year” award from the BioTech Breakthrough Awards as part of the program’s 2023 award recipients for its first of a kind protein sequencing instrument. “Since the groundbreaking […]

Quantum-Si to Participate at Two Upcoming Investor Conferences

BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 1, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in two upcoming investor conferences: Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum 6th Annual Evercore ISI HealthCONx Conference About the Canaccord Genuity MedTech Diagnostics and Digital Health […]

Quantum-Si Presents its Vision to Transform Genomics and Proteomics Research at ASHG 2023

BRANFORD, Conn.–(BUSINESS WIRE)–Oct. 31, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it will showcase next-generation benchtop protein sequencing instrument, Platinum™, and the Company’s vision to transform genomics and proteomics research, at the American Society of Human Genetics (ASHG) conference, in Washington, D.C., November 1-5. “Platinum, stands […]